Allred Capital Management, LLC Navidea Biopharmaceuticals, Inc. Transaction History

Allred Capital Management, LLC

$250 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$0.07 - $0.12 $12,099 - $20,742	172,850 Added 58.82%	466,688 $42,000
Q2 2023 Jul 20, 2023	BUY	$0.08 - $0.29 $10,328 - $37,439	129,100 Added 78.37%	293,838 $26,000
Q1 2023 May 09, 2023	BUY	$0.24 - $0.34 $13,032 - $18,462	54,300 Added 49.17%	164,738 $42,000
Q4 2022 Feb 14, 2023	BUY	$0.18 - $0.3 $11,376 - $18,960	63,200 Added 133.79%	110,438 $23,000
Q3 2022 Oct 27, 2022	BUY	$0.24 - $0.71 $2,496 - $7,384	10,400 Added 28.23%	47,238 $11,000
Q2 2022 Aug 09, 2022	SELL	$0.63 - $1.1 $9,313 - $16,262	-14,784 Reduced 28.64%	36,838 $26,000
Q1 2022 May 05, 2022	SELL	$0.72 - $1.2 $1,163 - $1,939	-1,616 Reduced 3.04%	51,622 $40,000
Q4 2021 Jan 25, 2022	SELL	$1.0 - $1.82 $11,750 - $21,385	-11,750 Reduced 18.08%	53,238 $53,000
Q3 2021 Oct 12, 2021	SELL	$1.53 - $1.85 $13,464 - $16,280	-8,800 Reduced 11.93%	64,988 $114,000
Q2 2021 Aug 05, 2021	BUY	$1.55 - $2.15 $15,166 - $21,037	9,785 Added 15.29%	73,788 $135,000
Q1 2021 May 06, 2021	BUY	$1.99 - $2.9 $22,043 - $32,123	11,077 Added 20.93%	64,003 $129,000
Q4 2020 Jan 21, 2021	SELL	$1.88 - $2.84 $23,268 - $35,150	-12,377 Reduced 18.95%	52,926 $113,000
Q3 2020 Oct 14, 2020	SELL	$2.69 - $4.95 $8,508 - $15,656	-3,163 Reduced 4.62%	65,303 $176,000
Q2 2020 Aug 13, 2020	BUY	$0.7 - $4.16 $33,556 - $199,422	47,938 Added 233.52%	68,466 $269,000
Q1 2020 Apr 17, 2020	SELL	$0.76 - $1.54 $2,736 - $5,544	-3,600 Reduced 14.92%	20,528 $15.6 Million
Q4 2019 Jan 13, 2020	BUY	$0.65 - $1.26 $8,326 - $16,140	12,810 Added 113.18%	24,128 $30,000
Q3 2019 Oct 07, 2019	SELL	$0.5 - $0.91 $4,050 - $7,371	-8,100 Reduced 41.71%	11,318 $8,000
Q2 2019 Jul 18, 2019	BUY	$0.62 - $3.6 $12,039 - $69,904	19,418 New	19,418 $11,000

Others Institutions Holding NAVB

# of Institutions

Shares Held

10.4K

Call Options Held

Put Options Held

View Full List

About NAVIDEA BIOPHARMACEUTICALS, INC.

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

More about NAVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allred Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allred Capital Management, LLC with notifications on news.

Account